CDEK
← All organizations

Optimer Pharmaceuticals

For profitContributed to NME

Also known as: Optimer Pharmaceuticals, Inc. | Optimer Pharmaceuticals LLC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Nov 1, 2004

First marketed drug

May 27, 2011

First NDA

May 27, 2011

Last known activity

Oct 10, 2012

Acquired by Cubist → Merck on Oct 24, 2013

Timeline

1990s

  1. Jan 1, 1998

    Optimer Pharmaceuticals— Founded

2010s

  1. May 27, 2011

    fidaxomicin— NDA Organization

  2. Oct 24, 2013

    Cubist— Acquired By

  3. Dec 8, 2014

    Merck— Now

Drugs by trial phase (3 distinct, 7 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (8)

Details

Founded
San Diego, CA, US Jan 1, 1998
First NDA
May 27, 2011
Last known activity
Oct 10, 2012

Designations held

  • Orphan drug
  • Priority review

Notes

Acquired by Cubist 30 Jul 2013